Comparative Pharmacology
Head-to-head clinical analysis: ADVIL DUAL ACTION WITH ACETAMINOPHEN versus MIDOL.
Peer-Reviewed Evidence
Head-to-head clinical analysis: ADVIL DUAL ACTION WITH ACETAMINOPHEN versus MIDOL.
ADVIL DUAL ACTION WITH ACETAMINOPHEN vs MIDOL
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Ibuprofen is a nonsteroidal anti-inflammatory drug (NSAID) that inhibits cyclooxygenase (COX-1 and COX-2) enzymes, reducing prostaglandin synthesis. Acetaminophen is an analgesic and antipyretic whose mechanism is not fully understood but involves inhibition of cyclooxygenase in the central nervous system and modulation of the endocannabinoid system.
Midol is a combination product containing acetaminophen (analgesic/antipyretic via COX inhibition in CNS), caffeine (adenosine receptor antagonist), and pyrilamine (H1 antihistamine). The primary mechanism for dysmenorrhea is prostaglandin synthesis inhibition by acetaminophen.
One caplet (ibuprofen 250 mg and acetaminophen 500 mg) orally every 8 hours while symptoms persist; maximum: 3 caplets per day.
Acetaminophen 500 mg, PAM Bromide 15 mg, Pyrilamine Maleate 15 mg: 2 tablets orally every 4-6 hours as needed for dysmenorrhea; maximum 10 tablets per day.
None Documented
None Documented
Clinical Note
moderateIopamidol + Metformin
"The risk or severity of adverse effects can be increased when Iopamidol is combined with Metformin."
Ibuprofen: 2-4 hours; Acetaminophen: 2-3 hours. Clinical context: Short half-lives require dosing every 6-8 hours. Extended half-life in overdose (acetaminophen >4 hours indicates toxicity).
Acetaminophen: 2-3 hours in adults; prolonged to 4-6 hours in neonates or hepatic impairment. Caffeine: 3-6 hours; prolonged in pregnancy or liver disease.
Ibuprofen: renal (90% as metabolites and conjugates, <10% unchanged); Acetaminophen: renal (85% as sulfate and glucuronide conjugates, 4% unchanged, 9% as cysteine and mercapturic acid conjugates; minor biliary).
Renal: >90% as acetaminophen glucuronide and sulfate conjugates; unchanged drug <5%. Biliary/fecal: <5%.
Category C
Category C
NSAID/Analgesic Combination
Analgesic Combination